Navigation Links
Epileptic Drug Found To Be Effective In Relieving Headache

Based on finding of a recent study researchers say the drug gabapentin (Neurontin) taken at 2,400 milligrams a day is an effective preventive // measure for people with chronic daily headaches.

Gabapentin is an approved anti-epileptic drug. Studies have also shown its success in treating other pain-related health issues like diabetic neuropathy, postherpetic neuralgia, and migraine headache. Since gabapentin often reduces migraines by more than 50 percent and chronic daily headaches often have migraine-like features, researchers in Australia conducted a double-blind, placebo-controlled study to determine the drug's specific effect on chronic daily headaches. This type of study is the gold standard of clinical research studies where neither the researchers nor the participants know who received the drug or an identical dummy substance, called a placebo.

For the study researchers recruited 133 patients who had headaches at least 15 days every month that lasted more than four hours at a time. The patients were randomly selected to receive gabapentin or a placebo for six weeks. After that period, none of the patients received either treatment for a week, and then each group switched to the opposite treatment for a second six weeks.

Results showed 36 percent of the patients taking 2,400 milligrams of gabapentin a day stopped having chronic daily headaches. Negative effects of the drug included vomiting, dizziness, dysarthria (problems speaking), sleepiness, and constipation.
'"/>




Page: 1

Related medicine news :

1. Epileptic Seizures Can Be Due to Heart Problem
2. Brain Septum Could Help In reducing Epileptic Seizures
3. Father Who Killed Epileptic Son Says He Misses Him
4. Epileptic Drug Found To Be Efficient As A Single Therapy
5. Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts
6. Light-activated Compound May Be of Help for Epileptics in Future
7. Anti-Epileptic Drug Intake May Result In Children With Mental Retardation
8. Fluoride Found Effective in Osteoporosis
9. Implantable Contact Lens Found Safe and Effective
10. Cancer hazard Found With Animal-Based Nutrients
11. Processed Meat, Diabetes connection Found
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Epileptic Drug Found Effective Relieving Headache

(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 New York ... family members, medical professionals, and researchers, covering a variety of topics related to ... collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan Kettering Cancer ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... research firm, has been recognized in the 2015 Aster Awards national competition for ... healthcare organization serving Ocean City and surrounding communities in Coastal Maryland and Southern ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Northern District of Ohio, Western Division (Case No. 3:15-cv-00397) involving the Implanon® ... women experienced spontaneous migration of their Implanon® implants, inability to locate the implants, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Burnaby sports physiotherapy clinic, ... the understanding and treatment of ankle sprains. A common sports injury, ankle sprains ... be dangerous if the condition augments and causes more disruption. Absolute PhysioCare’s blog ...
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to ... Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for Asterisk-based call ... display logic shows the script components to the agent only when wanted, and allows ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2
... Reporter , THURSDAY, Sept. 9 (HealthDay News) -- In 2000, ... fruit and vegetables people should eat, but a decade later ... those thresholds, health officials said Thursday. In fact, according ... 2009, 67.5 percent of adults ate fruit less than two ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, ... a quick MRI scan could tell doctors if a child,s ... that mental problems are developing. Researchers say the strategy ... to the age-old growth charts that tell pediatricians if kids ...
... This release is available in French . ... The Journal of Sexual Medicine has found that ... women,s chronic vulvovaginal pain may trigger more pain, but also ... took part in the study, conducted by the University of ...
... of the world,s population is infected with Mycobacterium tuberculosis ... of death world-wide. A new discovery, led by a ... of Medicine, offers hope for new approaches to the ... a novel mechanism that may contribute to immune recognition ...
... , THURSDAY, Sept. 9 (HealthDay News) -- A newly developed ... the kinds of medical problems that may face premature infants, ... a computational method to create a score based on factors ... the first three hours after birth. In a new study, ...
... A method that is widely used to predict the risk ... for millions of Americans, according to a study directed by ... the University of California, San Francisco. The method in ... which is used to estimate a patient,s 10-year risk of ...
Cached Medicine News:Health News:Most Americans Still Not Eating Enough Fruits, Veggies 2Health News:Most Americans Still Not Eating Enough Fruits, Veggies 3Health News:Brain Scans Could Spot Developmental Problems in Kids 2Health News:Romantic partner may play role in reducing vulvovaginal pain 2Health News:New dual recognition mechanism discovered in tuberculosis 2Health News:New dual recognition mechanism discovered in tuberculosis 3Health News:New Tool Aims to Predict Problems in Preemies 2Health News:Simplified heart-risk guideline may miscalculate risk for millions 2Health News:Simplified heart-risk guideline may miscalculate risk for millions 3
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 /PRNewswire/ ... a medical device company and manufacturer of the ... it has entered into non-exclusive Development Agreements with ... generation Tandem insulin pumps with the Dexcom G5 ... "Integrating Tandem,s next generation pump platform with ...
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... DANBURY, Conn., Sept. 22, 2011 Biodel Inc. (Nasdaq: ... President and Chief Executive Officer, will be presenting at the ... Hotel in New York.  The presentation is scheduled for Tuesday, ...  To listen to the live webcast or a replay of ...
... 22, 2011 Reportlinker.com announces that ... available in its catalogue: ... Packaging: Global Markets ... REPORT HIGHLIGHTS * ...
Cached Medicine Technology:Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 2Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 3Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 4Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 5Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 6Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 7Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 8Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 9Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 10Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 11Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 12Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 13Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 14Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 15Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 16Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 17Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 18Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 19Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 20Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 21Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets 22
... Size: 3.0 x 7.5 x ... Scleral Sponge II line designed by ... material is a closed cell sponge ... are soft with rounded edges to ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... mm. Half oval. The original Scleral Sponge II ... been modified by Dr. Joseph Olk with this ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
Medicine Products: